Stockscreener 앱 받기
16.78
2.56%
-0.44
시간 외 거래:
16.64
-0.14
-0.83%
전일 마감가:
$17.22
열려 있는:
$16.84
하루 거래량:
13.95M
Relative Volume:
6.81
시가총액:
$2.69B
수익:
$295.41M
순이익/손실:
$-49.64M
주가수익비율:
-51.25
EPS:
-0.3274
순현금흐름:
$-29.54M
1주 성능:
-1.70%
1개월 성능:
+30.79%
6개월 성능:
+4.09%
1년 성능:
+65.48%
1일 변동 폭
$16.43
$17.39
1주일 범위
$15.90
$19.52
52주 변동 폭
$9.9551
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
Compare ADPT vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
16.78 | 2.79B | 295.41M | -49.64M | -29.54M | -0.3274 |
TMO
Thermo Fisher Scientific Inc
|
461.69 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.76 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
546.09 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
124.33 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
357.00 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-09-30 | 개시 | Guggenheim | Buy |
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Stock Market Today: S&P 500 Futures Fall, Dow Gains Amid US-Iran Agreement, SPCX Stock Surge—Dave And Buster's, Western Digital In Focus - Benzinga
Adaptive Biotechnologies chief commercial officer sells $95,000 in shares By Investing.com - Investing.com India
Executive at Adaptive Biotechnologies (ADPT) sells 5,000 shares under 10b5-1 plan - Stock Titan
[144] Adaptive Biotechnologies Corp SEC Filing - Stock Titan
Adaptive Biotechnologies plans to separate MRD, Immune Medicine units - Investing.com
Adaptive Biotechnologies plans $250M convertible notes offering - Investing.com
Adaptive Biotechnologies stock falls on convertible debt plan By Investing.com - Investing.com India
Adaptive Biotechnologies proposes $250M convertible notes, plans MRD/Immune Medicine separation - TradingView
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering - The Manila Times
Adaptive Biotechnologies (NASDAQ: ADPT) to sell $250M converts and explore MRD–Immune Medicine split - Stock Titan
Adaptive Biotechnologies plans split: MRD tests vs AI immune unit - Stock Titan
Adaptive Biotechnologies lines up $250M note deal to repay debt, buy back shares - Stock Titan
Kennedy Capital Management LLC Trims Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
What Does an Adaptive Biotech Insider's Sale of Nearly 40,000 Shares Mean for Investors? - Yahoo Finance
Adaptive Biotechnologies Momentum Lifts Nasdaq Healthcare Focus - Kalkine Media
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpWhat's Next? - MarketBeat
Adaptive Biotechnologies (ADPT) Moves 9.7% Higher: Will This Strength Last? - Yahoo Finance
ADPT: Brokered notice to sell 5,000 shares (NASDAQ: ADPT) listed - Stock Titan
Adaptive Biotechnologies Corporation $ADPT Shares Sold by Amova Asset Management Americas Inc. - MarketBeat
Adaptive Biotechnologies (ADPT) shareholders back directors, pay and 2026 auditor - Stock Titan
Adaptive Biotechnologies CCO Bobulsky sells $198,000 in stock By Investing.com - Investing.com India
Adaptive Biotechnologies CCO Bobulsky sells $198,000 in stock - Investing.com UK
Adaptive Biotechnologies CPO Francis Lo sells $695k in stock - Investing.com UK
Adaptive Biotechnologies CPO Francis Lo sells $695k in stock By Investing.com - Investing.com India
Adaptive Biotechnologies (ADPT) CCO Bobulsky sells 11,000 shares under 10b5-1 plan - Stock Titan
ADPT (NASDAQ: ADPT) affiliate notifies planned sale after option exercise - Stock Titan
How The Adaptive Biotechnologies (ADPT) Narrative Is Shifting Around A US$20 Fair Value Anchor - Yahoo Finance
Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference - Yahoo Finance
Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026 - Insider Monkey
10 Best Growth Stocks Under $20 to Buy - Insider Monkey
Does ADPT’s clonoSEQ Spotlight at ASCO and EHA Reveal a Durable MRD Moat in Oncology? - simplywall.st
Jupiter Asset Management Ltd. Acquires 91,683 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Hits Day High with 9.75% Surge in Stock Price - MarketsMojo
Adaptive Biotechnologies Announces Extensive Presence at ASCO and EHA Conferences Showcasing clonoSEQ Test for MRD Assessment - Quiver Quantitative
Blood cancer monitoring test featured in 33 studies at major oncology meetings - Stock Titan
Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million - AOL.com
ADPT SEC FilingsAdaptive Biotechnologies 10-K, 10-Q, 8-K Forms - Stock Titan
Hear Adaptive Biotechnologies' June 3 investor talk live online - Stock Titan
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - The Manila Times
Adaptive Biotechnologies CFO Kyle Piskel sells $40,619 in stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies CFO Kyle Piskel sells $40,619 in stock - Investing.com
Adaptive Biotechnologies (ADPT) CFO tax-related share sale leaves 256,725 shares held - Stock Titan
UBS Group AG Purchases 257,947 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Proposed sale of 3,160 RSUs by ADPT (NASDAQ: ADPT) reported - Stock Titan
Viking firms hold 18.8% of Adaptive Biotechnologies (NASDAQ: ADPT) - Stock Titan
ADPT Stock Price, Quote & Chart | ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) - ChartMill
ADPT Maintained by Morgan Stanley -- Price Target Lowered to $18 - GuruFocus
Morgan Stanley Cuts Adaptive Biotechnologies (NASDAQ:ADPT) Price Target to $18.00 - MarketBeat
Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong MRD Growth And Raised Full Year Guidance - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adaptive Biotechnologies Corp 주식 (ADPT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN | Chief Commercial Officer, MRD |
Jun 11 '26 |
Sale |
19.00 |
5,000 |
95,000 |
411,775 |
1.63%
2.88%
자본화:
|
볼륨(24시간):